RY_SW01

N/A

Report date: 2026/05/22 11:05:27

Base Information

Drug NameRY_SW01
Drug Alias Name人脐带间充质干细胞（睿源生物）RY_SW01 UCMSCRY_SW01 cell injection therapy(Ruiyuan Biotechnology)RY_SW01RYSW-01 +[8] 
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsScleroderma, SystemicLupus NephritisKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesJiangsu Ruiyuan Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu Renocell Biotech Co LtdJiangsu Ruiyuan Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicLupus NephritisKidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A